Cargando…

'JEB'--a carboplatin based regimen for malignant germ cell tumours in children.

Between February 1986 and July 1988 a total of 21 children aged 1 to 16 years with malignant germ cell tumours (MGCT), 18 with either metastatic disease or unresectable primary tumour, received the JEB regimen - carboplatin dosage calculated from the EDTA glomerular filtration rate (approximately 60...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pinkerton, C. R., Broadbent, V., Horwich, A., Levitt, J., McElwain, T. J., Meller, S. T., Mott, M., Oakhill, A., Pritchard, J.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1990
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971831/ https://www.ncbi.nlm.nih.gov/pubmed/1696831

Ejemplares similares

The effect of carboplatin on renal function in patients with metastatic germ cell tumours.
por: Mason, M. D., et al.
Publicado: (1991)

'VEEP' in children with Hodgkin's disease--a regimen to decrease late sequelae.
por: O'Brien, M. E., et al.
Publicado: (1992)

The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP).
por: Peckham, M. J., et al.
Publicado: (1983)

Rapid VAC high dose melphalan regimen, a novel chemotherapy approach in childhood soft tissue sarcomas.
por: Pinkerton, C. R., et al.
Publicado: (1991)

Germ cell tumour chemotherapy.
por: Horwich, A.
Publicado: (1989)

Salvage therapy of germ cell tumours.
por: Horwich, A.
Publicado: (1995)

First report of junctional epidermolysis bullosa (JEB) in the Italian draft horse
por: Cappelli, Katia, et al.
Publicado: (2015)

Primary malignant mediastinal germ cell tumours: improved prognosis with platinum-based chemotherapy and surgery.
por: Childs, W. J., et al.
Publicado: (1993)

Brain metastases in malignant teratoma: a review of four years' experience and an assessment of the role of tumour markers.
por: Kaye, S. B., et al.
Publicado: (1979)

Paclitaxel–ifosfamide–carboplatin combination chemotherapy regimen in advanced uterine and adnexal malignant mixed Mullerian tumours
por: Kosmas, C, et al.
Publicado: (2011)

Childhood rhabdomyosarcoma: experience of the Children's Solid Tumour Group.
por: Kingston, J. E., et al.
Publicado: (1983)

Active immunotherapy as an adjunct to chemotherapy in the treatment of disseminated malignant melanoma: a pilot study.
por: Currie, G. A., et al.
Publicado: (1975)

Microsatellite instability in human testicular germ cell tumours.
por: Huddart, R. A., et al.
Publicado: (1995)

Outcome of children with resistant and relapsed Hodgkin's disease.
por: James, N. D., et al.
Publicado: (1992)

High-dose melphalan with autologous marrow for treatment of advanced neuroblastoma.
por: Pritchard, J., et al.
Publicado: (1982)

Carboplatin and renal function in children.
por: Stevens, M. C., et al.
Publicado: (1991)

Seven naturally variant loci serve as genetic modifiers of Lamc2(jeb) induced non-Herlitz junctional Epidermolysis Bullosa in mice
por: Sproule, Thomas J., et al.
Publicado: (2023)

Specific active immunotherapy does not prolong survival in surgically treated patients with stage IIB malignant melanoma and may promote early recurrence.
por: Hedley, D. W., et al.
Publicado: (1978)

Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours
por: Fosså, S D, et al.
Publicado: (1999)

Clonal diversification and histogenesis of malignant germ cell tumours
por: Oliver, Thomas R. W., et al.
Publicado: (2022)

Molecular cytogenetic analysis of adult testicular germ cell tumours and identification of regions of consensus copy number change.
por: Summersgill, B., et al.
Publicado: (1998)

Enhanced anti-tumour activity of carmustine (BCNU) with tumour necrosis factor in vitro and in vivo.
por: Jones, A. L., et al.
Publicado: (1990)

Advanced seminoma: treatment with cis-platinum-based combination chemotherapy or carboplatin (JM8).
por: Peckham, M. J., et al.
Publicado: (1985)

High-dose therapy including carboplatin adjusted for renal function in patients with relapsed or refractory germ cell tumour: outcome and prognostic factors.
por: Lyttelton, M. P., et al.
Publicado: (1998)

A mutation in the LAMC2 gene causes the Herlitz junctional epidermolysis bullosa (H-JEB) in two French draft horse breeds
por: Milenkovic, Dragan, et al.
Publicado: (2003)

Fertility and prognosis assessment between bleomycin/etoposide/cisplatin and paclitaxel/carboplatin chemotherapy regimens in the conservative treatment of malignant ovarian germ cell tumors: a multicenter and retrospective study
por: Chu, Ran, et al.
Publicado: (2022)

A Suppressor/Enhancer Screen in Drosophila Reveals a Role for Wnt-Mediated Lipid Metabolism in Primordial Germ Cell Migration
por: McElwain, Mark A., et al.
Publicado: (2011)

Malignant germ cell tumours of childhood: new associations of genomic imbalance
por: Palmer, R D, et al.
Publicado: (2007)

Chemotherapy for malignant melanoma: combinations and high doses produce more responses without survival benefit.
por: Lakhani, S., et al.
Publicado: (1990)

Tumour necrosis factor in man: clinical and biological observations.
por: Selby, P., et al.
Publicado: (1987)

Ifosfamide ±VP16 in Childhood' Malignancy: A Phase II (toxicity) Study
por: Pizer, B., et al.
Publicado: (1988)

Short duration, high dose, alternating chemotherapy in metastatic neuroblastoma. (ENSG 3C induction regimen). The European Neuroblastoma Study Group.
por: Pinkerton, C. R., et al.
Publicado: (1990)

Hypersensitivity to Carboplatin in Children with Malignancy
por: Ruggiero, Antonio, et al.
Publicado: (2017)

Malignant ovarian mixed germ cell tumour: a rare combination
por: Koshy, M, et al.
Publicado: (2005)

Malignant germ cell tumours of the testis express interferon-γ, but are resistant to endogenous interferon-γ
por: Schweyer, S, et al.
Publicado: (2003)

N-cadherin expression in malignant germ cell tumours of the testis
por: Bremmer, Felix, et al.
Publicado: (2012)

Clinical Challenges in the Management of Malignant Ovarian Germ Cell Tumours
por: Saani, Iqra, et al.
Publicado: (2023)

Phase I/II study of DHA–paclitaxel in combination with carboplatin in patients with advanced malignant solid tumours
por: Harries, M, et al.
Publicado: (2004)

Bleomycin, vincristine, cisplatin/bleomycin, etoposide, cisplatin chemotherapy: an alternating, dose intense regimen producing promising results in untreated patients with intermediate or poor prognosis malignant germ-cell tumours
por: Anthoney, D A, et al.
Publicado: (2004)

Advancing clinical and translational research in germ cell tumours (GCT): recommendations from the Malignant Germ Cell International Consortium
por: Fonseca, Adriana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c5tbq77ko7sk7rf7t9hu1glrtm